Skip to Content
MilliporeSigma

SML0288

Nepafenac

≥98% (HPLC)

Synonym(s):

2-Amino-3-benzoyl-benzeneacetamide, AHR 9434, AL 6515

Slide 1 of 1
Sign In to View Organizational & Contract Pricing

Select a Size

10 MG

$76.24

50 MG

$348.00

$76.24

List Price$89.70Save 15%
7 left in stockDetails
Request a Bulk Order

About This Item

Empirical Formula (Hill Notation):
C15H14N2O2
CAS Number:
78281-72-8
Molecular Weight:
254.28
MDL number:
MFCD08067732
UNSPSC Code:
12352200
PubChem Substance ID:
329825296
NACRES:
NA.77

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

100

assay

≥98% (HPLC)

form

powder

color

faintly yellow to dark yellow

solubility

DMSO: ≥5 mg/mL

storage temp.

room temp

SMILES string

NC(=O)Cc1cccc(c1N)C(=O)c2ccccc2

InChI

1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18)

InChI key

QEFAQIPZVLVERP-UHFFFAOYSA-N

Gene Information

human ... PTGS1(5742), PTGS2(5743)

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
1460317N0289SML1624
Nepafenac ≥98% (HPLC)

Sigma-Aldrich

SML0288

Nepafenac

Nepafenac United States Pharmacopeia (USP) Reference Standard

USP

1460317

Nepafenac

Nafamostat mesylate ≥98% (HPLC)

Sigma-Aldrich

N0289

Nafamostat mesylate

JNJ-63533054 ≥98% (HPLC)

Sigma-Aldrich

SML1624

JNJ-63533054

form

powder

form

-

form

powder

form

powder

assay

≥98% (HPLC)

assay

-

assay

≥98% (HPLC)

assay

≥98% (HPLC)

Quality Level

100

Quality Level

-

Quality Level

100

Quality Level

100

storage temp.

room temp

storage temp.

2-8°C

storage temp.

room temp

storage temp.

room temp

solubility

DMSO: ≥5 mg/mL

solubility

-

solubility

DMSO: 10 mg/mL, clear, H2O: >10 mg/mL

solubility

DMSO: 20 mg/mL, clear

color

faintly yellow to dark yellow

color

-

color

white to beige

color

white to beige

Biochem/physiol Actions

Nepafenac is a NSAID (nonsteroidal anti inflammatory drug) that is routinely used in opthamology to control pain following cataract surgery.
Nepafenac is a NSAID (nonsteroidal anti inflammatory drug) used in opthamology.
Nepafenac, a prodrug of amfenac,[1] is used in the treatment of diabetic retinopathy.[2] It is metabolized to its active form through intraocular enzymatic hydrolysis.[1] Nepafenac has a molecular weight of 254.28 kDa and effectively penetrates through the cornea.[3] Its molecule structure enables nepafenac to possess better permeability. Nepafenac has a low inhibitory effect on cyclooxygenase.[3]

pictograms

Environment
GHS09

signalword

Warning

hcodes

H410

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
032M4738V
0000110008
0000067165
0000067164
0000064793

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac
Walters T, et al.
Journal of Cataract and Refractive Surgery, 33(9), 1539-1545 (2007)
Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology
Kern TS, et al.
Diabetes, 56(2), 373-379 (2007)
Retinal Pharmacotherapeutics: Retinal Pharmacotherapeutics (2015)
Eric Chen et al.
Clinical ophthalmology (Auckland, N.Z.), 4, 1249-1252 (2010-12-15)
The purpose of this study is to determine the efficacy of combining topical nepafenac with monthly intravitreal injections of ranibizumab or bevacizumab in the treatment of recalcitrant exudative macular degeneration. This was a retrospective, consecutive case series of patients with
Haley Shelley et al.
AAPS PharmSciTech, 19(6), 2554-2563 (2018-06-28)
Nepafenac is a nonsteroidal anti-inflammatory drug (NSAID), currently only available as 0.1% ophthalmic suspension (Nevanac®). This study utilized hydroxypropyl-β-cyclodextrin (HPBCD) to increase the water solubility and trans-corneal permeation of nepafenac. The nepafenac-HPBCD complexation in the liquid and solid states were

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service